MAIO, MICHELE

MAIO, MICHELE  

Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze  

Mostra records
Risultati 1 - 20 di 389 (tempo di esecuzione: 0.002 secondi).
Titolo Data di pubblicazione Autore(i) File Abstract
5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach? 1-gen-2003 Sigalotti, L; Altomonte, M; Colizzi, F; Degan, M; Rupolo, M; Zagonel, V; Pinto, A; Gattei, V; Maio, M -
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story 1-gen-2007 Coral, S; Sigalotti, L; Covre, A; Nicolay, Hj; Natali, Pg; Maio, M -
5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications 1-gen-2002 Coral, S; Sigalotti, L; Altomonte, M; Engelsberg, A; Colizzi, F; Cattarossi, I; Maraskovsky, E; Jager, E; Seliger, B; Maio, M -
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients 1-gen-2006 Pilla, L; Patuzzo, R; Rivoltini, L; Maio, M; Pennacchioli, E; Lamaj, E; Maurichi, A; Massarut, S; Marchianò, A; Santantonio, C; Tosi, D; Arienti, F; Cova, A; Sovena, G; Piris, A; Nonaka, D; Bersani, I; Di Florio, A; Luigi, M; Srivastava, Pk; Hoos, A; Santinami, M; Parmiani, G -
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers" 1-gen-2008 Butterfield, Lh; Disis, Ml; Fox, Ba; Lee, Pp; Khleif, Sn; Thurin, M; Trinchieri, G; Wang, E; Wigginton, J; Chaussabel, D; Coukos, G; Dhodapkar, M; Håkansson, L; Janetzki, S; Kleen, To; Kirkwood, Jm; Maccalli, C; Maecker, H; Maio, M; Malyguine, A; Masucci, G; Palucka, Ak; Potter, Dm; Ribas, A; Rivoltini, L; Schendel, D; Seliger, B; Selvan, S; Slingluff CL, Jr; Stroncek, Df; Streicher, H; Wu, X; Zeskind, B; Zhao, Y; Zocca, Mb; Zwierzina, H; Marincola, Fm. -
Active immunization of melanoma patients with IL-2- or IL-4-transduced allogeneic melanoma cells 1-gen-1997 Arienti, F; Belli, F; Mazzocchi, A; Gallino, F; Napolitano, F; Melani, C; Colombo, Mp; Rivoltini, L; Maio, M; Parmiani, G -
Active immunization of melanoma patients with IL-2-transfected allogeneic melanoma cells. A phase I-II study 1-gen-1995 Arienti, F; Belli, F; Sulesuso, J; Maio, M; Mascheroni, L; Melani, C -
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: Evaluation of efficacy and tolerability 1-gen-1997 Belli, F; Arienti, F; Sulesuso, J; Clemente, C; Mascheroni, L; Cattelan, A; Sanantonio, C; Gallino, Gf; Melani, C; Rao, S; Colombo, Mp; Maio, M; Cascinelli, N; Parmiani, G -
Activity of ipilimumab at 10mg/kg in patients with advanced melanoma is independent of baseline prognostic factors 1-gen-2009 Schadendorf, D; Wolchok, J; Neyns, B; Lebbe, C; Harmankaya, K; Verschraegen, C; Chin, K; de Pril, V; Hoos, A; Maio, M -
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy 1-gen-2019 Maio, M.; Coukos, G.; Ferrone, S.; Fox, B. A.; Fridman, W. H.; Garcia, P. L.; Lahn, M.; Provendier, O.; Russo, V.; Ruttinger, D.; Shalabi, A.; Trajanoski, Z.; Viallet, J.; Wolchok, J. D.; Ibrahim, R. -
Adjuncts in diagnosis, prognosis, and clinical monitoring of breast, gynecologic, and hematolymphopoietic malignancies: Third Joint International Workshop, Lacco Ameno d'Ischia, Italy, October 2001 1-gen-2002 Giordano, Gg; Sigalotti, L; Maio, M -
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial 1-gen-2015 Eggermont, A. M. M.; Chiarion-Sileni, V.; Grob, J. -J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; Lebbe, C.; Ferraresi, V.; Smylie, M.; Weber, J. S.; Maio, M.; Konto, C.; Hoos, A.; de Pril, V.; Gurunath, R. K.; de Schaetzen, G.; Suciu, S.; Testori, A. -
Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial 1-gen-2019 Eggermont, A. M. M.; Chiarion-Sileni, V.; Grob, J. -J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; Lebbe, C.; Ferraresi, V.; Smylie, M.; Weber, J. S.; Maio, M.; Hosein, F.; de Pril, V.; Kicinski, M.; Suciu, S.; Testori, A. -
Adjuvant multipeptide vaccination in high-risk early melanoma patients 1-gen-2008 Filippazzi, P; Pilla, L; Patuzzo, R; Castelli, C; Maurichi, A; Tragni, G; Maio, M; Parmiani, G; Santinami, M; Rivoltini, L -
Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma 1-gen-2017 Weber, J.; Mandala, M.; Del Vecchio, M.; Gogas, H. J.; Arance, A. M.; Cowey, C. L.; Dalle, S.; Schenker, M.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Grob, J. -J.; Butler, M. O.; Middleton, M. R.; Maio, M.; Atkinson, V.; Queirolo, P.; Gonzalez, R.; Kudchadkar, R. R.; Smylie, M.; Meyer, N.; Mortier, L.; Atkins, M. B.; Long, G. V.; Bhatia, S.; Lebbe, C.; Rutkowski, P.; Yokota, K.; Yamazaki, N.; Kim, T. M.; De Pril, V.; Sabater, J.; Qureshi, A.; Larkin, J.; Ascierto, P. A. -
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial 1-gen-2020 Ascierto, P. A.; Del Vecchio, M.; Mandala, M.; Gogas, H.; Arance, A. M.; Dalle, S.; Cowey, C. L.; Schenker, M.; Grob, J. -J.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Butler, M. O.; Maio, M.; Middleton, M. R.; de la Cruz-Merino, L.; Arenberger, P.; Atkinson, V.; Hill, A.; Fecher, L. A.; Millward, M.; Khushalani, N. I.; Queirolo, P.; Lobo, M.; de Pril, V.; Loffredo, J.; Larkin, J.; Weber, J. -
Adjuvant pembrolizumab versus placebo in resected stage III melanoma 1-gen-2018 Eggermont, A. M. M.; Blank, C. U.; Mandala, M.; Long, G. V.; Atkinson, V.; Dalle, S.; Haydon, A.; Lichinitser, M.; Khattak, A.; Carlino, M. S.; Sandhu, S.; Larkin, J.; Puig, S.; Ascierto, P. A.; Rutkowski, P.; Schadendorf, D.; Koornstra, R.; Hernandez-Aya, L.; Maio, M.; Van Den Eertwegh, A. J. M.; Grob, J. -J.; Gutzmer, R.; Jamal, R.; Lorigan, P.; Ibrahim, N.; Marreaud, S.; Van Akkooi, A. C. J.; Suciu, S.; Robert, C. -
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial 1-gen-2008 Eggermont, A. M.; Suciu, S.; Santinami, M.; Testori, A.; Kruit, W. H.; Marsden, J.; Punt, C. J.; Salès, F.; Gore, M.; Mackie, R.; Kusic, Z.; Dummer, R.; Hauschild, A.; Musat, E.; Spatz, A.; Keilholz, U.; EORTC Melanoma, Group; Maio, M. -
Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial 1-gen-2018 Maio, M.; Lewis, K.; Demidov, L.; Mandalà, M.; Bondarenko, I.; Ascierto, P. A.; Herbert, C.; Mackiewicz, A.; Rutkowski, P.; Guminski, A.; Goodman, G. R.; Simmons, B.; Ye, C.; Yan, Y.; Schadendorf, D.; Cinat, G.; Fein, L. E.; Brown, M.; Haydon, A.; Khattak, A.; Mcneil, C.; Parente, P.; Power, J.; Roberts-Thomson, R.; Sandhu, S.; Underhill, C.; Varma, S.; Berger, T.; Awada, A.; Blockx, N.; Buyse, V.; Mebis, J.; Franke, F. A.; Jobim de Azevedo, S.; Silva Lazaretti, N.; Jamal, R.; Mihalcioiu, C.; Petrella, T.; Savage, K.; Song, X.; Wong, R.; Dabelic, N.; Plestina, S.; Vojnovic, Z.; Arenberger, P.; Kocak, I.; Krajsova, I.; Kubala, E.; Melichar, B.; Vantuchova, Y.; Putnik, K.; Dreno, B.; Dutriaux, C.; Grob, J. -J.; Joly, P.; Lacour, J. -P.; Meyer, N.; Mortier, L.; Thomas, L.; Fluck, M.; Gambichler, T.; Hassel, J.; Hauschild, A.; Donnellan, P.; Mccaffrey, J.; Power, D.; Ariad, S.; Bar-Sela, G.; Hendler, D.; Ron, I.; Schachter, J.; Berruti, A.; Bianchi, L.; Chiarion Sileni, V.; Cognetti, F.; Danielli, R.; Di Giacomo, A. M.; Gianni, L.; Goldhirsch, A.; Guida, M.; Marchetti, P.; Queirolo, P.; Santoro, A.; Kapiteijn, E.; Ferreira, P.; Gafton, G.; Makarova, Y.; Andric, Z.; Babovic, N.; Jovanovic, D.; Kandolf Sekulovic, L.; Cohen, G.; Dreosti, L.; Vorobiof, D.; Curiel Garcia, M. T.; Diaz Beveridge, R.; Majem Tarruella, M.; Marquez Rodas, I.; Puliats Rodriguez, J. -M.; Rueda Dominguez, A.; Maroti, M.; Papworth, K.; Michielin, O.; Brown, E.; Corrie, P.; Harries, M.; Kumar, S.; Martin-Clavijo, A.; Middleton, M.; Patel, P.; Talbot, T.; Agarwala, S.; Chapman, P.; Conry, R.; Doolittle, G.; Gangadhar, T.; Hallmeyer, S.; Hamid, O.; Hernandez-Aya, L.; Johnson, D.; Kass, F.; Kolevska, T.; Lunin, S.; Salama, A.; Sikic, B.; Somer, B.; Spigel, D.; Whitman, E.; Brim8, Investigators -
Analisi funzionale e fenotipica dei T linfociti isolati dal sangue periferico di pazienti affetti da AIDS 1-gen-1985 Imberti, L; Maio, M; Poggi, A; Pierri, I; Indiveri, F -